Dr. M. Adham Salkeni, MD, FRCPC
Claim this profileVirginia Cancer Specialists
Studies Pancreatic Cancer
Studies Cancer
4 reported clinical trials
7 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
2Cancer
Stage IV
EphA5 positive
HER2 negative
Affiliated Hospitals
Clinical Trials M. Adham Salkeni, MD, FRCPC is currently running
Ivaltinostat + Capecitabine
for Pancreatic Cancer
This trial tests ivaltinostat with capecitabine in patients with advanced pancreatic cancer who have not worsened after initial treatment. The goal is to find a safe and effective dose and to see if this combination can better control the cancer. Capecitabine is a medication that is converted into another drug in the body, showing better selectivity and tolerability in tumor tissues.
Recruiting3 awards Phase 1 & 211 criteria
Antibody-Drug Conjugate
for Advanced Cancer
This trial is testing MBRC-101, a new drug, in patients with advanced cancers that haven't improved with other treatments. It aims to find the best dose and check its safety and effectiveness. The study will also observe how the drug behaves in the body and if it causes any immune reactions.
Recruiting1 award Phase 1 & 216 criteria
More about M. Adham Salkeni, MD, FRCPC
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments M. Adham Salkeni, MD, FRCPC has experience with
- Botensilimab
- Gemcitabine
- Nab-paclitaxel
- MBRC-101
- Capecitabine
- Ivaltinostat
Breakdown of trials M. Adham Salkeni, MD, FRCPC has run
Pancreatic Cancer
Lung Cancer
Endometrial Cancer
Cervical Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does M. Adham Salkeni, MD, FRCPC specialize in?
M. Adham Salkeni, MD, FRCPC focuses on Pancreatic Cancer and Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is M. Adham Salkeni, MD, FRCPC currently recruiting for clinical trials?
Yes, M. Adham Salkeni, MD, FRCPC is currently recruiting for 2 clinical trials in Fairfax Virginia. If you're interested in participating, you should apply.
Are there any treatments that M. Adham Salkeni, MD, FRCPC has studied deeply?
Yes, M. Adham Salkeni, MD, FRCPC has studied treatments such as Botensilimab, Gemcitabine, Nab-paclitaxel.
What is the best way to schedule an appointment with M. Adham Salkeni, MD, FRCPC?
Apply for one of the trials that M. Adham Salkeni, MD, FRCPC is conducting.
What is the office address of M. Adham Salkeni, MD, FRCPC?
The office of M. Adham Salkeni, MD, FRCPC is located at: Virginia Cancer Specialists, Fairfax, Virginia 22031 United States. This is the address for their practice at the Virginia Cancer Specialists.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.